# Acute psilocin increased cortical activity in rat

**Authors:** Junhong Liu, Yuanyuan Wang, Ke Xia, Jinfeng Wu, Danhao Zheng, Aoling Cai, Haitao Yan, Ruibin Su

PMC · DOI: 10.3389/fnins.2026.1593703 · Frontiers in Neuroscience · 2026-02-04

## TL;DR

This study shows that psilocin increases brain activity and connectivity in rats, similar to effects seen in humans.

## Contribution

The study combines BOLD fMRI and EGR1 immunofluorescence to reveal psilocin's acute effects on rat brain activity and connectivity.

## Key findings

- Psilocin increased brain activity in the frontal, temporal, and parietal cortex, hippocampus, and striatum in rats.
- Functional connectivity was enhanced between regions like the cingulate cortex and dorsal striatum.
- Psilocin up-regulated EGR1 levels in cortical and striatal regions, indicating consistent activation.

## Abstract

Psilocin, a naturally occurring hallucinogenic component of magic mushrooms, exerts notable psychoactive effects in both humans and rodents. However, the underlying mechanisms remain not fully understood. Blood-oxygenation level-dependent (BOLD) functional magnetic resonance imaging (fMRI) is a valuable tool in many preclinical and clinical trials for investigating changes of brain activity and functional connectivity (FC) due to its noninvasive nature and widespread availability. However, fMRI effects of psilocin on rats have not been thoroughly explored. This study aimed to explore the impact of psilocin on rats’ brain activity by combining BOLD fMRI and immunofluorescence (IF) of EGR1, an immediate early gene (IEG) closely related to depressive symptoms. Ten minutes after psilocin hydrochloride injection (2.0 mg/kg, i.p.), elevated brain activity was detected in the frontal, temporal, and parietal cortex (including the cingulate cortex and retrosplenial cortex), hippocampus, and striatum. Moreover, a region-of-interest (ROI) -wise FC analysis matrix indicated enhanced interconnectivity of several regions, such as the cingulate cortex, dorsal striatum, prelimbic, and limbic regions. Further seed-based analyses revealed increased FC of cingulate cortex with the cortical and striatal areas. In addition to the fMRI observations, acute psilocin led to an increase in the EGR1 level in most cortical and striatal regions, indicating a consistent activation throughout the cortical and striatal areas. In conclusion, the psilocin-induced hyperactive state in rats is congruent to that in humans, and the increased brain activity, enhanced functional connectivity and up-regulation of EGR1 may be responsible for its pharmacological effects.

## Linked entities

- **Genes:** EGR1 (early growth response 1) [NCBI Gene 1958]
- **Chemicals:** psilocin (PubChem CID 4980), psilocin hydrochloride (PubChem CID 164879132)
- **Species:** Rattus norvegicus (taxon 10116)

## Full-text entities

- **Genes:** Htr1a (5-hydroxytryptamine receptor 1A) [NCBI Gene 24473] {aka 5HT1A, RAT5HT1A}, Egr1 (early growth response 1) [NCBI Gene 24330] {aka Krox-24, NGFI-A, Ngf1, Ngfi, zif-268}, HTR7 (5-hydroxytryptamine receptor 7) [NCBI Gene 3363] {aka 5-HT7}, FOS (Fos proto-oncogene, AP-1 transcription factor subunit) [NCBI Gene 2353] {aka AP-1, C-FOS, p55}, HTR1D (5-hydroxytryptamine receptor 1D) [NCBI Gene 3352] {aka 5-HT1D, HT1DA, HTR1DA, HTRL, RDC4}, TMEM245 (transmembrane protein 245) [NCBI Gene 23731] {aka C9orf5, CG-2, CG2}, HTR1B (5-hydroxytryptamine receptor 1B) [NCBI Gene 3351] {aka 5-HT-1B, 5-HT-1D-beta, 5-HT1B, 5-HT1DB, HTR1D2, HTR1DB}, HTR1A (5-hydroxytryptamine receptor 1A) [NCBI Gene 3350] {aka 5-HT-1A, 5-HT1A, 5HT1a, ADRB2RL1, ADRBRL1, G-21}, HTR6 (5-hydroxytryptamine receptor 6) [NCBI Gene 3362] {aka 5-HT6, 5-HT6R}, EGR1 (early growth response 1) [NCBI Gene 1958] {aka AT225, G0S30, KROX-24, NGFI-A, TIS8, ZIF-268}, HTR3A (5-hydroxytryptamine receptor 3A) [NCBI Gene 3359] {aka 5-HT-3, 5-HT3A, 5-HT3R, 5HT3R, HTR3}, MAMLD1 (mastermind like domain containing 1) [NCBI Gene 10046] {aka CG1, CXorf6, F18, HYSP2}, ACACA (acetyl-CoA carboxylase alpha) [NCBI Gene 31] {aka ACAC, ACACAD, ACACalpha, ACC, ACC1, ACCA}, HTR2C (5-hydroxytryptamine receptor 2C) [NCBI Gene 3358] {aka 5-HT1C, 5-HT2C, 5-HTR2C, 5HTR2C, HTR1C}, DRD2 (dopamine receptor D2) [NCBI Gene 1813] {aka D2DR, D2R}, HTR2A (5-hydroxytryptamine receptor 2A) [NCBI Gene 3356] {aka 5-HT2A, HTR2}
- **Diseases:** MDD (MESH:D003865), hyperactive (MESH:D006948), reduced CBF (MESH:D054318), HTR (MESH:D006258), anxiety (MESH:D001007), schizophrenia (MESH:D012559), psychiatric disorders (MESH:D001523), depression (MESH:D003866), delusion (MESH:D063726), hallucination (MESH:D006212)
- **Chemicals:** Isoflurane (MESH:D007530), acetylcholine (MESH:D000109), GABA (MESH:D005680), norepinephrine (MESH:D009638), glutamate (MESH:D018698), phosphate (MESH:D010710), Psilocin (MESH:C009105), adenosine (MESH:D000241), histamine (MESH:D006632), saline (MESH:D012965), sodium pentobarbital (MESH:D010424), sucrose (MESH:D013395), LSD (MESH:D008238), paraformaldehyde (MESH:C003043), 5-HT (MESH:D012701), glucose (MESH:D005947), Psilocybin (MESH:D011562), DAPI (MESH:C007293), dopamine (MESH:D004298), PBS (MESH:D007854), PFA (-), N-acetylaspartate (MESH:C000179)
- **Species:** Mus musculus (house mouse, species) [taxon 10090], Rodentia (rodent, order) [taxon 9989], Homo sapiens (human, species) [taxon 9606], Rattus norvegicus (brown rat, species) [taxon 10116]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12915336/full.md

## Figures

6 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12915336/full.md

## References

75 references — full list in the complete paper: https://tomesphere.com/paper/PMC12915336/full.md

---
Source: https://tomesphere.com/paper/PMC12915336